within Pharmacolibrary.Drugs.ATC.G;

model G01AX12
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 1.6666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G01AX12</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ciclopirox is a synthetic antifungal agent used mainly in topical formulations to treat dermatophytoses, candidiasis, and seborrheic dermatitis. It is not typically used systemically and is approved for topical use in various countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for topical application in adults; no published clinical pharmacokinetic studies available for oral, intravenous, or systemic administration.</p><h4>References</h4><ol><li><p>Gupta, AK, &amp; Talukder, M (2022). Efinaconazole in Onychomycosis. <i>American journal of clinical dermatology</i> 23(2) 207–218. DOI:<a href=\"https://doi.org/10.1007/s40257-021-00660-1\">10.1007/s40257-021-00660-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34902110/\">https://pubmed.ncbi.nlm.nih.gov/34902110</a></p></li><li><p>Bohn, M, &amp; Kraemer, KT (2000). Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. <i>Journal of the American Academy of Dermatology</i> 43(4 Suppl) S57–S69. DOI:<a href=\"https://doi.org/10.1067/mjd.2000.109072\">10.1067/mjd.2000.109072</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11051135/\">https://pubmed.ncbi.nlm.nih.gov/11051135</a></p></li><li><p>Gupta, AK, et al., &amp; Foley, KA (2014). Topical therapy for toenail onychomycosis: an evidence-based review. <i>American journal of clinical dermatology</i> 15(6) 489–502. DOI:<a href=\"https://doi.org/10.1007/s40257-014-0096-2\">10.1007/s40257-014-0096-2</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25257931/\">https://pubmed.ncbi.nlm.nih.gov/25257931</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G01AX12;
